C. Ignacio

发表

Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence

D. Richman, L. Bacheler, H. Günthard, 2003, Proceedings of the National Academy of Sciences of the United States of America.

In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues

D. Richman, D. Havlir, J. Wong, 1997, Journal of virology.

In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells

S. Pillai, J. Wong, M. Strain, 2010, PLoS pathogens.

Evolution of Envelope Sequences of Human Immunodeficiency Virus Type 1 in Cellular Reservoirs in the Setting of Potent Antiviral Therapy

Alan S. Perelson, Douglas D. Richman, Simon D. W. Frost, 1999, Journal of Virology.

Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.

D. Richman, H. Günthard, S. Frost, 2001, The Journal of infectious diseases.

Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.

R. Haubrich, D. Richman, H. Günthard, 2000, The Journal of infectious diseases.

HIV persists throughout deep tissues with repopulation from multiple anatomical sources.

S. Gianella, C. Ignacio, Davey M. Smith, 2020, The Journal of clinical investigation.

Can’t Work From Home: Pooled Nucleic Acid Testing of Laboratory Workers During the COVID-19 Pandemic

S. Gianella, C. Ignacio, Davey M. Smith, 2021, Open forum infectious diseases.

Biomimetic Virus-Like Particles as Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tools

N. Steinmetz, C. Ignacio, S. Chan, 2020, ACS nano.

The impact of the COVID-19 pandemic among migrants in shelters in Tijuana, Baja California, Mexico

R. Garfein, C. Ignacio, S. Strathdee, 2022, BMJ Global Health.

A novel codon insert in protease of clade B HIV type 1.

D. Richman, K. Squires, C. Ignacio, 2009, AIDS research and human retroviruses.

1 Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV- 2 2 and endemic coronavirus infection 3

D. Burton, D. Nemazee, A. Ward, 2020 .

The prostate as a reservoir for HIV-1

D. Richman, S. Little, J. Wong, 2004, AIDS.

Human Immunodeficiency Virus Replication and Genotypic Resistance in Blood and Lymph Nodes after a Year of Potent Antiretroviral Therapy

D. Richman, H. Günthard, D. Havlir, 1998, Journal of Virology.

Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection

D. Burton, D. Nemazee, A. Ward, 2021, Nature Communications.

Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection

D. Burton, D. Nemazee, A. Ward, 2020, bioRxiv.

Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro.

R. Haubrich, R. Shafer, D. Richman, 2008, The Journal of infectious diseases.

Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection

D. Richman, S. Little, S. Frost, 2008, Journal of Virology.

Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.

R. Haubrich, C. Ignacio, Davey M. Smith, 2006, The Journal of infectious diseases.

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

Ben Murrell, Nico Pfeifer, Florian Klein, 2017, Nature Medicine.

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

J. Corbeil, D. Richman, D. Havlir, 1994, Journal of virology.

Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral Therapy

D. Richman, I. Grant, H. Günthard, 2005, Journal of Virology.

Prevalence and predictive value of intermittent viremia with combination hiv therapy.

M. Hirsch, D. Richman, H. Günthard, 2001, JAMA.

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

D. Richman, H. Günthard, D. Havlir, 1997, Science.

Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples.

D. Richman, H. Günthard, D. Havlir, 1998, AIDS Research and Human Retroviruses.

No Evidence of SARS-CoV-2 Seminal Shedding Despite SARS-CoV-2 Persistence in the Upper Respiratory Tract

C. Ignacio, Davey M. Smith, Stephen A. Rawlings, 2020, Open forum infectious diseases.

Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc

D. Richman, S. Little, S. Gianella, 2017, Journal of Virology.

Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.

Sergei L. Kosakovsky Pond, D. Richman, I. Grant, 2012, Virology.

Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus

D. Richman, S. Little, C. Petropoulos, 2003, AIDS.

Comparison of methods to detect HIV dual infection.

Susan Little, Douglas Richman, D. Richman, 2010, AIDS research and human retroviruses.

Rapid Sequencing of Complete env Genes from Primary HIV-1 Samples.

Yan Guo, Ben Murrell, Pham Phung, 2016, Virus evolution.

HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption

R. Kaul, C. Kovacs, T. Chun, 2020, Journal of Virology.

Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine.

D. Havlir, J. Wong, M. Strain, 2005, The Journal of infectious diseases.

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

D. Richman, H. Günthard, D. Havlir, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

Matthew C Strain, Diane V Havlir, D. Richman, 2005, The Journal of infectious diseases.

The use of pooled viral load testing to identify antiretroviral treatment failure

R. Haubrich, D. Richman, S. Little, 2009, AIDS.

Productive Infection Maintains a Dynamic Steady State of Residual Viremia in Human Immunodeficiency Virus Type 1-Infected Persons Treated with Suppressive Antiretroviral Therapy for Five Years

Mario Clerici, Diane V. Havlir, D. Havlir, 2003, Journal of Virology.

High Prevalence of HIV-1 Drug Resistance and Dynamics of Transmission Among High-Risk Populations in Port-au-Prince, Haiti.

S. Gianella, C. Ignacio, Davey M. Smith, 2020, Journal of acquired immune deficiency syndromes.

Incidence of HIV superinfection following primary infection.

D. Richman, S. Little, E. Daar, 2004, JAMA.

HIV drug resistance acquired through superinfection

D. Richman, S. Little, C. Petropoulos, 2005, AIDS.

OP 1.4 – 00053 Definitive evidence of a persistent HIV reservoir in human brain myeloid cells despite ART

S. Gianella, C. Ignacio, A. Chaillon, 2022, Journal of virus eradication.

Quantification of HIV RNA and Human Herpesvirus DNA in Seminal Plasma.

S. Gianella, C. Ignacio, M. Massanella, 2015, Bio-protocol.

Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy

F. Zanini, S. Gianella, C. Ignacio, 2018, Journal of acquired immune deficiency syndromes.

Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region

T. Patterson, C. Ignacio, S. Strathdee, 2021, medRxiv.

Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.

D. Richman, A. Gamst, I. Grant, 2009, Virology.

Pooled Nucleic Acid Testing to Detect Antiretroviral Treatment Failure in HIV-Infected Patients in Mozambique

C. Ignacio, Davey M. Smith, E. Noormahomed, 2015, Journal of acquired immune deficiency syndromes.

Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.

Simon D W Frost, D. Richman, S. Little, 2007, The Journal of infectious diseases.

SARS-CoV-2 Seroconversion in an Adult Horse with Direct Contact to a COVID-19 Individual

C. Ignacio, Davey M. Smith, A. Chaillon, 2022, Viruses.

Performing rapid autopsy for the interrogation of HIV reservoirs.

S. Gianella, C. Ignacio, Davey M. Smith, 2020, AIDS.

Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy

D. Margolis, S. Gianella, G. Jiang, 2023, The Journal of clinical investigation.

Evaluation of Archival HIV DNA in Brain and Lymphoid Tissues

R. Ellis, S. Gianella, C. Ignacio, 2023, Journal of virology.

Virus-Like Particles as Positive Controls for COVID-19 RT-LAMP Diagnostic Assays.

N. Steinmetz, C. Ignacio, S. Chan, 2021, Biomacromolecules.

Novel codon insert in HIV type 1 clade B reverse transcriptase associated with low-level viremia during antiretroviral therapy.

D. Richman, S. Gianella, C. Ignacio, 2014, AIDS research and human retroviruses.

A novel codon insert in protease of clade B HIV type 1.

D. Richman, K. Squires, C. Ignacio, 2009, AIDS Research and Human Retroviruses.

A Combined Screening Platform for HIV Treatment Failure and Resistance

D. Richman, S. Little, C. Ignacio, 2012, PloS one.